MICHELLE GEERTS: Open Payments
NPI 1396415188 · ROCKLIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,118 in 102 payments from 22 companies in 2025. Trend: 2023 $2,652 · 2024 $2,291 · 2025 $2,118
Food & beverage: $2,118
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $380 |
| PFIZER INC. | 13 | $255 |
| GlaxoSmithKline, LLC. | 12 | $246 |
| ABBVIE INC. | 8 | $149 |
| AstraZeneca Pharmaceuticals LP | 3 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $123 |
| Boston Scientific Corporation | 5 | $116 |
| Lilly USA, LLC | 6 | $108 |
| Exact Sciences Corporation | 4 | $97 |
| Amgen Inc. | 4 | $85 |
Products named: NURTEC ODT, Wegovy, JARDIANCE, AREXVY, TRELEGY ELLIPTA, AIRSUPRA, Rybelsus, Ozempic.
Industry payments across CA — which companies pay providers there.
